Characteristics of Pancreatic Neuroendocrine Tumors (PNET) patients treated with Peptide Receptor Radionuclide Therapy (PRRT) in two Canadian centers – A real-world evidence study

#3747

Introduction: PRRT is a standard practice for treatment of metastatic midgut neuroendocrine tumors. PNET patients who progressed on prior therapy are also considered for PRRT if accessible via special access.

Aim(s): To explore real world data on metastatic PNET patients treated with PRRT.

Materials and methods: Retrospective chart review was done for adult PNET patients at LRCP and TOH from 2011/6/01-2021/06/01. Demographic/clinical data was collected and descriptive statistics were performed noting that LRCP is a PRRT referral centre for TOH.

Conference:

Presenting Author: Tsvetkova E

Authors: Tsvetkova E, Welch S, Laidley D, Sachdeva R, Goodwin R,

Keywords: Pancreatic Neuroendocrine Tumor, Peptide Receptor Radionuclide Therapy, Real World Experience,